Wang W, Li T, Wu K
Cell Death Discov. 2025; 11(1):93.
PMID: 40064873
PMC: 11894105.
DOI: 10.1038/s41420-025-02376-1.
Zeng G, Zhao C, Li G, Huang Z, Zhuang J, Liang X
Comput Struct Biotechnol J. 2025; 27:531-540.
PMID: 39968174
PMC: 11833646.
DOI: 10.1016/j.csbj.2025.01.011.
Stepanskyy N, Pascal M, Asselin K, Brazier L, Meliani J, Tissot S
Sci Rep. 2025; 15(1):5886.
PMID: 39966423
PMC: 11836361.
DOI: 10.1038/s41598-025-88895-4.
Derbal Y
Clin Med Insights Oncol. 2025; 19():11795549241311408.
PMID: 39776668
PMC: 11701910.
DOI: 10.1177/11795549241311408.
Bin Masroni M, Koay E, Lee V, Ng S, Tan S, Tan K
Exp Mol Med. 2025; 57(1):30-40.
PMID: 39774289
PMC: 11799181.
DOI: 10.1038/s12276-024-01387-9.
Adaptive Significance of Non-coding RNAs: Insights from Cancer Biology.
McDonald J
Mol Biol Evol. 2025; 42(1).
PMID: 39761690
PMC: 11725524.
DOI: 10.1093/molbev/msae269.
Phylogenetic analysis and detection of positive selection in the SIRT gene family across vertebrates.
Zhou Q, Yang X, Li D, Li J, Peng L, He W
Sci Rep. 2025; 15(1):848.
PMID: 39757258
PMC: 11701078.
DOI: 10.1038/s41598-025-85344-0.
Evolutionary rescue model informs strategies for driving cancer cell populations to extinction.
Dabi A, Brown J, Gatenby R, Jones C, Schrider D
bioRxiv. 2024; .
PMID: 39651238
PMC: 11623570.
DOI: 10.1101/2024.11.26.625315.
Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.
Duraj T, Kalamian M, Zuccoli G, Maroon J, DAgostino D, Scheck A
BMC Med. 2024; 22(1):578.
PMID: 39639257
PMC: 11622503.
DOI: 10.1186/s12916-024-03775-4.
Neural Influences on Tumor Progression Within the Central Nervous System.
Lv W, Wang Y
CNS Neurosci Ther. 2024; 30(10):e70097.
PMID: 39469896
PMC: 11519750.
DOI: 10.1111/cns.70097.
Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens.
Chi W, Hu Y, Huang H, Kuo H, Lin S, Kuo C
J Biomed Sci. 2024; 31(1):94.
PMID: 39379923
PMC: 11463125.
DOI: 10.1186/s12929-024-01082-x.
Pan-cancer analysis reveals that TK1 promotes tumor progression by mediating cell proliferation and Th2 cell polarization.
Li Z, Wu Z, You X, Tang N
Cancer Cell Int. 2024; 24(1):329.
PMID: 39343871
PMC: 11440694.
DOI: 10.1186/s12935-024-03515-x.
Genetic variation drives cancer cell adaptation to ECM stiffness.
Wang T, Sawhney S, Morgan D, Bennett R, Rashmi R, Estecio M
Proc Natl Acad Sci U S A. 2024; 121(39):e2403062121.
PMID: 39302966
PMC: 11441511.
DOI: 10.1073/pnas.2403062121.
Modeling tumors as complex ecosystems.
Aguade-Gorgorio G, Anderson A, Sole R
iScience. 2024; 27(9):110699.
PMID: 39280631
PMC: 11402243.
DOI: 10.1016/j.isci.2024.110699.
PDCD10 Is a Key Player in TMZ-Resistance and Tumor Cell Regrowth: Insights into Its Underlying Mechanism in Glioblastoma Cells.
Zhu Y, Kim S, Chen Z, Will R, Zhong R, Dammann P
Cells. 2024; 13(17.
PMID: 39273014
PMC: 11394141.
DOI: 10.3390/cells13171442.
Spatial resolved transcriptomics reveals distinct cross-talk between cancer cells and tumor-associated macrophages in intrahepatic cholangiocarcinoma.
Dong Z, Zhang M, Qu L, Zou J, Yang Y, Ma Y
Biomark Res. 2024; 12(1):100.
PMID: 39256888
PMC: 11389341.
DOI: 10.1186/s40364-024-00648-z.
The evolutionary theory of cancer: challenges and potential solutions.
Laplane L, Maley C
Nat Rev Cancer. 2024; 24(10):718-733.
PMID: 39256635
PMC: 11627115.
DOI: 10.1038/s41568-024-00734-2.
Gut microbiome influences efficacy of Endostatin combined with PD-1 blockade against colorectal cancer.
Xu J, Tian Y, Zhao B, Hu D, Wu S, Ma J
Mol Biomed. 2024; 5(1):37.
PMID: 39251538
PMC: 11383918.
DOI: 10.1186/s43556-024-00200-3.
Cell-cell fusion in cancer: The next cancer hallmark?.
Shultes P, Weaver D, Tadele D, Barker-Clarke R, Scott J
Int J Biochem Cell Biol. 2024; 175():106649.
PMID: 39186970
PMC: 11752790.
DOI: 10.1016/j.biocel.2024.106649.
Evolutionary Measures Show that Recurrence of DCIS is Distinct from Progression to Breast Cancer.
Fortunato A, Mallo D, Cisneros L, King L, Khan A, Curtis C
medRxiv. 2024; .
PMID: 39185534
PMC: 11343254.
DOI: 10.1101/2024.08.15.24311949.